FDA Approves AOP Health’s Rapiblyk for Atrial Fibrillation and Atrial Flutter

Approval was based on the combined results from five studies of adults with supraventricular tachycardia.

admin

Leave a Reply

Your email address will not be published. Required fields are marked *

Powered by WordPress | WP Newspaper by WP Mag Plus